Source: Fox News
Summary
Presley Gerber, 27, son of Cindy Crawford, died at a California rehab facility, raising questions about addiction treatment. Addiction specialist Dr. Drew Pinsky said Gerber’s case highlights the progressive nature of substance use disorder and the risks of patients directing their own care. Gerber reportedly used ibogaine, an unapproved psychoactive compound, which Pinsky warned has no magic and often leads to relapse. Federal agencies classify ibogaine as a Schedule I substance due to risks of fatal heart arrhythmias. Experts say opioid addiction has a worse prognosis than many cancers and that rehab does not guarantee recovery. Toxicology results are pending, but emergency logs indicate a suspected overdose and cardiac arrest.
Our Reading
This guidance has been heard before.
Substance use disorder is progressive and deadly.
Patients often choose unproven treatments over medical protocols.
Rehab does not guarantee recovery or safety.
The risk of relapse remains high even after treatment.
The idea that addiction is a chronic, worsening condition is not new.
Author: Evan Null
Presley Gerber’s Death and the Limits of Rehab
Presley Gerber, the 27-year-old son of Cindy Crawford, died at a California rehab facility, sparking questions about the effectiveness of addiction treatment. His death has drawn attention to the dangers of substance use disorder and the challenges of recovery. Gerber reportedly used ibogaine, a psychoactive compound not approved by the FDA, which has been linked to serious health risks.
Dr. Drew Pinsky’s Concerns About Patient-Directed Care
Addiction specialist Dr. Drew Pinsky expressed concern that Gerber appeared to be making decisions about his own care, which he said is not ideal. Pinsky emphasized that substance use disorder is a progressive condition that often ends in death, even with treatment. He warned that alternative therapies like ibogaine do not offer a cure and that most patients who use them eventually relapse.
Ibogaine: A Risky, Unapproved Treatment
Ibogaine, derived from an African shrub, has been studied as a potential treatment for addiction but is not approved by the FDA. It is classified as a Schedule I substance in the U.S. due to documented risks, including fatal heart arrhythmias. Pinsky said he has seen patients use ibogaine for decades, but none have found a lasting solution to their addiction.
The Dangers of Relapse in Recovery
Dr. Nicholas Kardaris, an addiction expert, noted that the period immediately following rehab is often the most dangerous for patients. He explained that relapse can be fatal because of lowered tolerance, which turns a usual dose into a deadly one. Experts recommend evidence-based treatments, including FDA-approved medications like buprenorphine and methadone, for opioid use disorders.
The Opioid Crisis and the Need for Evidence-Based Care
Experts stress that opioid addiction has a worse prognosis than many cancers and that treatment must be guided by medical evidence. Gerber’s case highlights the ongoing challenges of the opioid crisis and the risks of relying on unproven or alternative therapies. While toxicology results are still pending, his death has raised concerns about the safety and effectiveness of modern treatment approaches.
